Camosunate Children (1 - 6 Yrs)

Camosunate Children (1–6 Years) – Artemisinin-Based Combination Therapy (ACT)

Description:

Camosunate Children is an artemisinin-based combination therapy (ACT) specially formulated for the effective treatment of uncomplicated malaria in children aged 1 to 6 years. It combines Artesunate and Amodiaquine, two powerful antimalarial agents, to provide fast and reliable relief from Plasmodium falciparum infections.

Key Features:

• Suitable for children aged 1–6 years

• Contains Artesunate + Amodiaquine

• WHO-recommended ACT for malaria treatment

• Blister-packed tablets for accurate pediatric dosing

• Fast-acting and well-tolerated

• Helps prevent malaria recurrence and resistance

Indications:

• Treatment of acute uncomplicated malaria caused by Plasmodium falciparum

• Effective in areas with chloroquine resistance

Dosage & Administration:

• As prescribed by a qualified healthcare provider

• Dosage based on child’s age and weight

• Usually given once daily for 3 consecutive days

Storage:

• Store in a cool, dry place below 30°C

• Keep out of reach of children

Caution:

• For oral use only

• Complete the full course even if symptoms improve

• Not recommended for use in children under 1 year